Poniard Pharmaceuticals, Inc.
Poniard Pharmaceuticals, Inc. (PARD) Stock Competitors & Peer Comparison
See (PARD) competitors and their performances in Stock Market.
Peer Comparison Table: Biotechnology Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| PARD | $0.00 | +0.00% | 150 | -0.01 | -$0.01 | N/A |
| NONOF | $54.70 | -20.49% | 240.2B | 14.83 | $3.65 | +3.02% |
| CSLLY | $88.85 | +1.05% | 173.2B | 32.88 | $2.72 | +1.49% |
| CMXHF | $173.54 | +0.31% | 84B | 32.38 | $5.36 | +1.60% |
| UCBJF | $218.19 | +2.92% | 41.5B | 34.09 | $6.40 | +0.73% |
| UCBJY | $106.80 | +3.20% | 41.4B | 33.55 | $3.19 | +0.74% |
| ARGNF | $547.60 | +0.00% | 33.5B | 33.45 | $16.37 | N/A |
| ODTC | $22,005.00 | +29.44% | 24.1B | 1.07 | $20,580.00 | N/A |
| IVBXF | $12.27 | +1.66% | 21.6B | -1261.00 | -$0.01 | N/A |
| WXXWY | $8.42 | +4.60% | 17.2B | 38.27 | $0.22 | N/A |
Stock Comparison
PARD vs NONOF Comparison July 2025
PARD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PARD stands at 150. In comparison, NONOF has a market cap of 240.2B. Regarding current trading prices, PARD is priced at $0.00, while NONOF trades at $54.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PARD currently has a P/E ratio of -0.01, whereas NONOF's P/E ratio is 14.83. In terms of profitability, PARD's ROE is -1.87%, compared to NONOF's ROE of +0.81%. Regarding short-term risk, PARD is less volatile compared to NONOF. This indicates potentially lower risk in terms of short-term price fluctuations for PARD.Check NONOF's competition here
PARD vs CSLLY Comparison July 2025
PARD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PARD stands at 150. In comparison, CSLLY has a market cap of 173.2B. Regarding current trading prices, PARD is priced at $0.00, while CSLLY trades at $88.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PARD currently has a P/E ratio of -0.01, whereas CSLLY's P/E ratio is 32.88. In terms of profitability, PARD's ROE is -1.87%, compared to CSLLY's ROE of +0.26%. Regarding short-term risk, PARD is less volatile compared to CSLLY. This indicates potentially lower risk in terms of short-term price fluctuations for PARD.Check CSLLY's competition here
PARD vs CMXHF Comparison July 2025
PARD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PARD stands at 150. In comparison, CMXHF has a market cap of 84B. Regarding current trading prices, PARD is priced at $0.00, while CMXHF trades at $173.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PARD currently has a P/E ratio of -0.01, whereas CMXHF's P/E ratio is 32.38. In terms of profitability, PARD's ROE is -1.87%, compared to CMXHF's ROE of +0.15%. Regarding short-term risk, PARD is less volatile compared to CMXHF. This indicates potentially lower risk in terms of short-term price fluctuations for PARD.Check CMXHF's competition here
PARD vs UCBJF Comparison July 2025
PARD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PARD stands at 150. In comparison, UCBJF has a market cap of 41.5B. Regarding current trading prices, PARD is priced at $0.00, while UCBJF trades at $218.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PARD currently has a P/E ratio of -0.01, whereas UCBJF's P/E ratio is 34.09. In terms of profitability, PARD's ROE is -1.87%, compared to UCBJF's ROE of +0.03%. Regarding short-term risk, PARD and UCBJF have similar daily volatility (0.00).Check UCBJF's competition here
PARD vs UCBJY Comparison July 2025
PARD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PARD stands at 150. In comparison, UCBJY has a market cap of 41.4B. Regarding current trading prices, PARD is priced at $0.00, while UCBJY trades at $106.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PARD currently has a P/E ratio of -0.01, whereas UCBJY's P/E ratio is 33.55. In terms of profitability, PARD's ROE is -1.87%, compared to UCBJY's ROE of +0.03%. Regarding short-term risk, PARD is less volatile compared to UCBJY. This indicates potentially lower risk in terms of short-term price fluctuations for PARD.Check UCBJY's competition here
PARD vs ARGNF Comparison July 2025
PARD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PARD stands at 150. In comparison, ARGNF has a market cap of 33.5B. Regarding current trading prices, PARD is priced at $0.00, while ARGNF trades at $547.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PARD currently has a P/E ratio of -0.01, whereas ARGNF's P/E ratio is 33.45. In terms of profitability, PARD's ROE is -1.87%, compared to ARGNF's ROE of +0.16%. Regarding short-term risk, PARD is less volatile compared to ARGNF. This indicates potentially lower risk in terms of short-term price fluctuations for PARD.Check ARGNF's competition here
PARD vs ODTC Comparison July 2025
PARD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PARD stands at 150. In comparison, ODTC has a market cap of 24.1B. Regarding current trading prices, PARD is priced at $0.00, while ODTC trades at $22,005.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PARD currently has a P/E ratio of -0.01, whereas ODTC's P/E ratio is 1.07. In terms of profitability, PARD's ROE is -1.87%, compared to ODTC's ROE of +0.07%. Regarding short-term risk, PARD and ODTC have similar daily volatility (0.00).Check ODTC's competition here
PARD vs IVBXF Comparison July 2025
PARD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PARD stands at 150. In comparison, IVBXF has a market cap of 21.6B. Regarding current trading prices, PARD is priced at $0.00, while IVBXF trades at $12.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PARD currently has a P/E ratio of -0.01, whereas IVBXF's P/E ratio is -1261.00. In terms of profitability, PARD's ROE is -1.87%, compared to IVBXF's ROE of -0.01%. Regarding short-term risk, PARD is less volatile compared to IVBXF. This indicates potentially lower risk in terms of short-term price fluctuations for PARD.Check IVBXF's competition here
PARD vs WXXWY Comparison July 2025
PARD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PARD stands at 150. In comparison, WXXWY has a market cap of 17.2B. Regarding current trading prices, PARD is priced at $0.00, while WXXWY trades at $8.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PARD currently has a P/E ratio of -0.01, whereas WXXWY's P/E ratio is 38.27. In terms of profitability, PARD's ROE is -1.87%, compared to WXXWY's ROE of +0.06%. Regarding short-term risk, PARD is less volatile compared to WXXWY. This indicates potentially lower risk in terms of short-term price fluctuations for PARD.Check WXXWY's competition here
PARD vs SBHMY Comparison July 2025
PARD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PARD stands at 150. In comparison, SBHMY has a market cap of 16.7B. Regarding current trading prices, PARD is priced at $0.00, while SBHMY trades at $18.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PARD currently has a P/E ratio of -0.01, whereas SBHMY's P/E ratio is 64.31. In terms of profitability, PARD's ROE is -1.87%, compared to SBHMY's ROE of +0.11%. Regarding short-term risk, PARD is less volatile compared to SBHMY. This indicates potentially lower risk in terms of short-term price fluctuations for PARD.Check SBHMY's competition here
PARD vs WXIBF Comparison July 2025
PARD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PARD stands at 150. In comparison, WXIBF has a market cap of 16.5B. Regarding current trading prices, PARD is priced at $0.00, while WXIBF trades at $4.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PARD currently has a P/E ratio of -0.01, whereas WXIBF's P/E ratio is 36.77. In terms of profitability, PARD's ROE is -1.87%, compared to WXIBF's ROE of +0.06%. Regarding short-term risk, PARD is less volatile compared to WXIBF. This indicates potentially lower risk in terms of short-term price fluctuations for PARD.Check WXIBF's competition here
PARD vs SBMFF Comparison July 2025
PARD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PARD stands at 150. In comparison, SBMFF has a market cap of 16B. Regarding current trading prices, PARD is priced at $0.00, while SBMFF trades at $0.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PARD currently has a P/E ratio of -0.01, whereas SBMFF's P/E ratio is 89.20. In terms of profitability, PARD's ROE is -1.87%, compared to SBMFF's ROE of +0.11%. Regarding short-term risk, PARD is less volatile compared to SBMFF. This indicates potentially lower risk in terms of short-term price fluctuations for PARD.Check SBMFF's competition here
PARD vs GNMSF Comparison July 2025
PARD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PARD stands at 150. In comparison, GNMSF has a market cap of 13.7B. Regarding current trading prices, PARD is priced at $0.00, while GNMSF trades at $222.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PARD currently has a P/E ratio of -0.01, whereas GNMSF's P/E ratio is 12.91. In terms of profitability, PARD's ROE is -1.87%, compared to GNMSF's ROE of +0.26%. Regarding short-term risk, PARD is less volatile compared to GNMSF. This indicates potentially lower risk in terms of short-term price fluctuations for PARD.Check GNMSF's competition here
PARD vs TRSBF Comparison July 2025
PARD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PARD stands at 150. In comparison, TRSBF has a market cap of 11.2B. Regarding current trading prices, PARD is priced at $0.00, while TRSBF trades at $4.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PARD currently has a P/E ratio of -0.01, whereas TRSBF's P/E ratio is 39.50. In terms of profitability, PARD's ROE is -1.87%, compared to TRSBF's ROE of +0.11%. Regarding short-term risk, PARD is less volatile compared to TRSBF. This indicates potentially lower risk in terms of short-term price fluctuations for PARD.Check TRSBF's competition here
PARD vs AKBLF Comparison July 2025
PARD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PARD stands at 150. In comparison, AKBLF has a market cap of 6.4B. Regarding current trading prices, PARD is priced at $0.00, while AKBLF trades at $28.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PARD currently has a P/E ratio of -0.01, whereas AKBLF's P/E ratio is 43.86. In terms of profitability, PARD's ROE is -1.87%, compared to AKBLF's ROE of +0.18%. Regarding short-term risk, PARD and AKBLF have similar daily volatility (0.00).Check AKBLF's competition here
PARD vs ABCZF Comparison July 2025
PARD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PARD stands at 150. In comparison, ABCZF has a market cap of 5.1B. Regarding current trading prices, PARD is priced at $0.00, while ABCZF trades at $22.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PARD currently has a P/E ratio of -0.01, whereas ABCZF's P/E ratio is 2225.00. In terms of profitability, PARD's ROE is -1.87%, compared to ABCZF's ROE of -0.01%. Regarding short-term risk, PARD and ABCZF have similar daily volatility (0.00).Check ABCZF's competition here
PARD vs INCPF Comparison July 2025
PARD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PARD stands at 150. In comparison, INCPF has a market cap of 4.9B. Regarding current trading prices, PARD is priced at $0.00, while INCPF trades at $3.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PARD currently has a P/E ratio of -0.01, whereas INCPF's P/E ratio is -108.67. In terms of profitability, PARD's ROE is -1.87%, compared to INCPF's ROE of -0.05%. Regarding short-term risk, PARD and INCPF have similar daily volatility (0.00).Check INCPF's competition here
PARD vs LABFF Comparison July 2025
PARD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PARD stands at 150. In comparison, LABFF has a market cap of 4.6B. Regarding current trading prices, PARD is priced at $0.00, while LABFF trades at $90.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PARD currently has a P/E ratio of -0.01, whereas LABFF's P/E ratio is 28.95. In terms of profitability, PARD's ROE is -1.87%, compared to LABFF's ROE of +0.38%. Regarding short-term risk, PARD and LABFF have similar daily volatility (0.00).Check LABFF's competition here
PARD vs TLPPF Comparison July 2025
PARD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PARD stands at 150. In comparison, TLPPF has a market cap of 4.6B. Regarding current trading prices, PARD is priced at $0.00, while TLPPF trades at $13.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PARD currently has a P/E ratio of -0.01, whereas TLPPF's P/E ratio is 135.40. In terms of profitability, PARD's ROE is -1.87%, compared to TLPPF's ROE of +0.14%. Regarding short-term risk, PARD is less volatile compared to TLPPF. This indicates potentially lower risk in terms of short-term price fluctuations for PARD.Check TLPPF's competition here
PARD vs AAVXF Comparison July 2025
PARD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PARD stands at 150. In comparison, AAVXF has a market cap of 4.4B. Regarding current trading prices, PARD is priced at $0.00, while AAVXF trades at $70.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PARD currently has a P/E ratio of -0.01, whereas AAVXF's P/E ratio is -20.20. In terms of profitability, PARD's ROE is -1.87%, compared to AAVXF's ROE of -2.11%. Regarding short-term risk, PARD and AAVXF have similar daily volatility (0.00).Check AAVXF's competition here
PARD vs GNNSF Comparison July 2025
PARD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PARD stands at 150. In comparison, GNNSF has a market cap of 4.3B. Regarding current trading prices, PARD is priced at $0.00, while GNNSF trades at $2.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PARD currently has a P/E ratio of -0.01, whereas GNNSF's P/E ratio is -25.00. In terms of profitability, PARD's ROE is -1.87%, compared to GNNSF's ROE of -0.06%. Regarding short-term risk, PARD and GNNSF have similar daily volatility (0.00).Check GNNSF's competition here
PARD vs CAMRF Comparison July 2025
PARD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PARD stands at 150. In comparison, CAMRF has a market cap of 4.2B. Regarding current trading prices, PARD is priced at $0.00, while CAMRF trades at $71.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PARD currently has a P/E ratio of -0.01, whereas CAMRF's P/E ratio is 56.35. In terms of profitability, PARD's ROE is -1.87%, compared to CAMRF's ROE of +0.17%. Regarding short-term risk, PARD is less volatile compared to CAMRF. This indicates potentially lower risk in terms of short-term price fluctuations for PARD.Check CAMRF's competition here
PARD vs ZLDPF Comparison July 2025
PARD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PARD stands at 150. In comparison, ZLDPF has a market cap of 3.9B. Regarding current trading prices, PARD is priced at $0.00, while ZLDPF trades at $54.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PARD currently has a P/E ratio of -0.01, whereas ZLDPF's P/E ratio is -20.07. In terms of profitability, PARD's ROE is -1.87%, compared to ZLDPF's ROE of -0.13%. Regarding short-term risk, PARD is less volatile compared to ZLDPF. This indicates potentially lower risk in terms of short-term price fluctuations for PARD.Check ZLDPF's competition here
PARD vs SHJBF Comparison July 2025
PARD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PARD stands at 150. In comparison, SHJBF has a market cap of 3B. Regarding current trading prices, PARD is priced at $0.00, while SHJBF trades at $1.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PARD currently has a P/E ratio of -0.01, whereas SHJBF's P/E ratio is -10.94. In terms of profitability, PARD's ROE is -1.87%, compared to SHJBF's ROE of -0.27%. Regarding short-term risk, PARD is less volatile compared to SHJBF. This indicates potentially lower risk in terms of short-term price fluctuations for PARD.Check SHJBF's competition here
PARD vs REGMF Comparison July 2025
PARD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PARD stands at 150. In comparison, REGMF has a market cap of 3B. Regarding current trading prices, PARD is priced at $0.00, while REGMF trades at $5.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PARD currently has a P/E ratio of -0.01, whereas REGMF's P/E ratio is -13.32. In terms of profitability, PARD's ROE is -1.87%, compared to REGMF's ROE of -0.48%. Regarding short-term risk, PARD is less volatile compared to REGMF. This indicates potentially lower risk in terms of short-term price fluctuations for PARD.Check REGMF's competition here
PARD vs BVNKF Comparison July 2025
PARD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PARD stands at 150. In comparison, BVNKF has a market cap of 2.9B. Regarding current trading prices, PARD is priced at $0.00, while BVNKF trades at $36.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PARD currently has a P/E ratio of -0.01, whereas BVNKF's P/E ratio is 13.88. In terms of profitability, PARD's ROE is -1.87%, compared to BVNKF's ROE of +0.12%. Regarding short-term risk, PARD and BVNKF have similar daily volatility (0.00).Check BVNKF's competition here
PARD vs BVNRY Comparison July 2025
PARD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PARD stands at 150. In comparison, BVNRY has a market cap of 2.8B. Regarding current trading prices, PARD is priced at $0.00, while BVNRY trades at $12.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PARD currently has a P/E ratio of -0.01, whereas BVNRY's P/E ratio is 13.82. In terms of profitability, PARD's ROE is -1.87%, compared to BVNRY's ROE of +0.12%. Regarding short-term risk, PARD is less volatile compared to BVNRY. This indicates potentially lower risk in terms of short-term price fluctuations for PARD.Check BVNRY's competition here
PARD vs TKBIF Comparison July 2025
PARD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PARD stands at 150. In comparison, TKBIF has a market cap of 2.8B. Regarding current trading prices, PARD is priced at $0.00, while TKBIF trades at $23.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PARD currently has a P/E ratio of -0.01, whereas TKBIF's P/E ratio is 18.71. In terms of profitability, PARD's ROE is -1.87%, compared to TKBIF's ROE of N/A. Regarding short-term risk, PARD and TKBIF have similar daily volatility (0.00).Check TKBIF's competition here
PARD vs MPSYF Comparison July 2025
PARD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PARD stands at 150. In comparison, MPSYF has a market cap of 2.8B. Regarding current trading prices, PARD is priced at $0.00, while MPSYF trades at $73.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PARD currently has a P/E ratio of -0.01, whereas MPSYF's P/E ratio is -12.13. In terms of profitability, PARD's ROE is -1.87%, compared to MPSYF's ROE of -1.84%. Regarding short-term risk, PARD is less volatile compared to MPSYF. This indicates potentially lower risk in terms of short-term price fluctuations for PARD.Check MPSYF's competition here
PARD vs ONTTF Comparison July 2025
PARD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PARD stands at 150. In comparison, ONTTF has a market cap of 2.7B. Regarding current trading prices, PARD is priced at $0.00, while ONTTF trades at $2.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PARD currently has a P/E ratio of -0.01, whereas ONTTF's P/E ratio is -13.43. In terms of profitability, PARD's ROE is -1.87%, compared to ONTTF's ROE of -0.27%. Regarding short-term risk, PARD is less volatile compared to ONTTF. This indicates potentially lower risk in terms of short-term price fluctuations for PARD.Check ONTTF's competition here
PARD vs GENSF Comparison July 2025
PARD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PARD stands at 150. In comparison, GENSF has a market cap of 2.2B. Regarding current trading prices, PARD is priced at $0.00, while GENSF trades at $33.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PARD currently has a P/E ratio of -0.01, whereas GENSF's P/E ratio is -416.12. In terms of profitability, PARD's ROE is -1.87%, compared to GENSF's ROE of +0.01%. Regarding short-term risk, PARD is less volatile compared to GENSF. This indicates potentially lower risk in terms of short-term price fluctuations for PARD.Check GENSF's competition here
PARD vs ASPHF Comparison July 2025
PARD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PARD stands at 150. In comparison, ASPHF has a market cap of 2.2B. Regarding current trading prices, PARD is priced at $0.00, while ASPHF trades at $5.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PARD currently has a P/E ratio of -0.01, whereas ASPHF's P/E ratio is -32.36. In terms of profitability, PARD's ROE is -1.87%, compared to ASPHF's ROE of -0.70%. Regarding short-term risk, PARD is less volatile compared to ASPHF. This indicates potentially lower risk in terms of short-term price fluctuations for PARD.Check ASPHF's competition here
PARD vs IUGNF Comparison July 2025
PARD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PARD stands at 150. In comparison, IUGNF has a market cap of 1.9B. Regarding current trading prices, PARD is priced at $0.00, while IUGNF trades at $0.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PARD currently has a P/E ratio of -0.01, whereas IUGNF's P/E ratio is -26.00. In terms of profitability, PARD's ROE is -1.87%, compared to IUGNF's ROE of -0.96%. Regarding short-term risk, PARD is less volatile compared to IUGNF. This indicates potentially lower risk in terms of short-term price fluctuations for PARD.Check IUGNF's competition here
PARD vs BTTAY Comparison July 2025
PARD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PARD stands at 150. In comparison, BTTAY has a market cap of 1.9B. Regarding current trading prices, PARD is priced at $0.00, while BTTAY trades at $24.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PARD currently has a P/E ratio of -0.01, whereas BTTAY's P/E ratio is -67.31. In terms of profitability, PARD's ROE is -1.87%, compared to BTTAY's ROE of +0.05%. Regarding short-term risk, PARD is less volatile compared to BTTAY. This indicates potentially lower risk in terms of short-term price fluctuations for PARD.Check BTTAY's competition here
PARD vs GLPGF Comparison July 2025
PARD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PARD stands at 150. In comparison, GLPGF has a market cap of 1.9B. Regarding current trading prices, PARD is priced at $0.00, while GLPGF trades at $28.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PARD currently has a P/E ratio of -0.01, whereas GLPGF's P/E ratio is -5.57. In terms of profitability, PARD's ROE is -1.87%, compared to GLPGF's ROE of -0.06%. Regarding short-term risk, PARD is less volatile compared to GLPGF. This indicates potentially lower risk in terms of short-term price fluctuations for PARD.Check GLPGF's competition here
PARD vs BRCTF Comparison July 2025
PARD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PARD stands at 150. In comparison, BRCTF has a market cap of 1.7B. Regarding current trading prices, PARD is priced at $0.00, while BRCTF trades at $19.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PARD currently has a P/E ratio of -0.01, whereas BRCTF's P/E ratio is 18.07. In terms of profitability, PARD's ROE is -1.87%, compared to BRCTF's ROE of +0.77%. Regarding short-term risk, PARD is less volatile compared to BRCTF. This indicates potentially lower risk in terms of short-term price fluctuations for PARD.Check BRCTF's competition here
PARD vs BIESF Comparison July 2025
PARD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PARD stands at 150. In comparison, BIESF has a market cap of 1.6B. Regarding current trading prices, PARD is priced at $0.00, while BIESF trades at $32.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PARD currently has a P/E ratio of -0.01, whereas BIESF's P/E ratio is -44.44. In terms of profitability, PARD's ROE is -1.87%, compared to BIESF's ROE of +0.05%. Regarding short-term risk, PARD and BIESF have similar daily volatility (0.00).Check BIESF's competition here
PARD vs PHMMF Comparison July 2025
PARD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PARD stands at 150. In comparison, PHMMF has a market cap of 1.6B. Regarding current trading prices, PARD is priced at $0.00, while PHMMF trades at $91.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PARD currently has a P/E ratio of -0.01, whereas PHMMF's P/E ratio is 68.59. In terms of profitability, PARD's ROE is -1.87%, compared to PHMMF's ROE of +0.10%. Regarding short-term risk, PARD is less volatile compared to PHMMF. This indicates potentially lower risk in terms of short-term price fluctuations for PARD.Check PHMMF's competition here
PARD vs PPTDF Comparison July 2025
PARD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PARD stands at 150. In comparison, PPTDF has a market cap of 1.5B. Regarding current trading prices, PARD is priced at $0.00, while PPTDF trades at $11.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PARD currently has a P/E ratio of -0.01, whereas PPTDF's P/E ratio is 15.32. In terms of profitability, PARD's ROE is -1.87%, compared to PPTDF's ROE of +0.26%. Regarding short-term risk, PARD is less volatile compared to PPTDF. This indicates potentially lower risk in terms of short-term price fluctuations for PARD.Check PPTDF's competition here
PARD vs CSBTF Comparison July 2025
PARD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PARD stands at 150. In comparison, CSBTF has a market cap of 1.5B. Regarding current trading prices, PARD is priced at $0.00, while CSBTF trades at $37.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PARD currently has a P/E ratio of -0.01, whereas CSBTF's P/E ratio is -291.54. In terms of profitability, PARD's ROE is -1.87%, compared to CSBTF's ROE of -0.15%. Regarding short-term risk, PARD and CSBTF have similar daily volatility (0.00).Check CSBTF's competition here
PARD vs NURPF Comparison July 2025
PARD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PARD stands at 150. In comparison, NURPF has a market cap of 1.4B. Regarding current trading prices, PARD is priced at $0.00, while NURPF trades at $11.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PARD currently has a P/E ratio of -0.01, whereas NURPF's P/E ratio is 15.40. In terms of profitability, PARD's ROE is -1.87%, compared to NURPF's ROE of +0.49%. Regarding short-term risk, PARD is less volatile compared to NURPF. This indicates potentially lower risk in terms of short-term price fluctuations for PARD.Check NURPF's competition here
PARD vs ASCLF Comparison July 2025
PARD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PARD stands at 150. In comparison, ASCLF has a market cap of 1.3B. Regarding current trading prices, PARD is priced at $0.00, while ASCLF trades at $1.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PARD currently has a P/E ratio of -0.01, whereas ASCLF's P/E ratio is -34.50. In terms of profitability, PARD's ROE is -1.87%, compared to ASCLF's ROE of -0.09%. Regarding short-term risk, PARD is less volatile compared to ASCLF. This indicates potentially lower risk in terms of short-term price fluctuations for PARD.Check ASCLF's competition here
PARD vs BRAXF Comparison July 2025
PARD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PARD stands at 150. In comparison, BRAXF has a market cap of 1.3B. Regarding current trading prices, PARD is priced at $0.00, while BRAXF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PARD currently has a P/E ratio of -0.01, whereas BRAXF's P/E ratio is -0.03. In terms of profitability, PARD's ROE is -1.87%, compared to BRAXF's ROE of -2.49%. Regarding short-term risk, PARD is less volatile compared to BRAXF. This indicates potentially lower risk in terms of short-term price fluctuations for PARD.Check BRAXF's competition here
PARD vs MEOBF Comparison July 2025
PARD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PARD stands at 150. In comparison, MEOBF has a market cap of 1.2B. Regarding current trading prices, PARD is priced at $0.00, while MEOBF trades at $0.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PARD currently has a P/E ratio of -0.01, whereas MEOBF's P/E ratio is -16.17. In terms of profitability, PARD's ROE is -1.87%, compared to MEOBF's ROE of -0.15%. Regarding short-term risk, PARD is less volatile compared to MEOBF. This indicates potentially lower risk in terms of short-term price fluctuations for PARD.Check MEOBF's competition here
PARD vs SNBIF Comparison July 2025
PARD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PARD stands at 150. In comparison, SNBIF has a market cap of 1B. Regarding current trading prices, PARD is priced at $0.00, while SNBIF trades at $14.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PARD currently has a P/E ratio of -0.01, whereas SNBIF's P/E ratio is -34.00. In terms of profitability, PARD's ROE is -1.87%, compared to SNBIF's ROE of -0.92%. Regarding short-term risk, PARD is less volatile compared to SNBIF. This indicates potentially lower risk in terms of short-term price fluctuations for PARD.Check SNBIF's competition here
PARD vs HBMHF Comparison July 2025
PARD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PARD stands at 150. In comparison, HBMHF has a market cap of 931.6M. Regarding current trading prices, PARD is priced at $0.00, while HBMHF trades at $1.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PARD currently has a P/E ratio of -0.01, whereas HBMHF's P/E ratio is 36.67. In terms of profitability, PARD's ROE is -1.87%, compared to HBMHF's ROE of +0.02%. Regarding short-term risk, PARD is less volatile compared to HBMHF. This indicates potentially lower risk in terms of short-term price fluctuations for PARD.Check HBMHF's competition here
PARD vs CSPHF Comparison July 2025
PARD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PARD stands at 150. In comparison, CSPHF has a market cap of 910.9M. Regarding current trading prices, PARD is priced at $0.00, while CSPHF trades at $0.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PARD currently has a P/E ratio of -0.01, whereas CSPHF's P/E ratio is -62.50. In terms of profitability, PARD's ROE is -1.87%, compared to CSPHF's ROE of -0.14%. Regarding short-term risk, PARD is less volatile compared to CSPHF. This indicates potentially lower risk in terms of short-term price fluctuations for PARD.Check CSPHF's competition here
PARD vs PHGUF Comparison July 2025
PARD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PARD stands at 150. In comparison, PHGUF has a market cap of 787.9M. Regarding current trading prices, PARD is priced at $0.00, while PHGUF trades at $1.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PARD currently has a P/E ratio of -0.01, whereas PHGUF's P/E ratio is -57.50. In terms of profitability, PARD's ROE is -1.87%, compared to PHGUF's ROE of -0.06%. Regarding short-term risk, PARD is less volatile compared to PHGUF. This indicates potentially lower risk in terms of short-term price fluctuations for PARD.Check PHGUF's competition here
PARD vs BPMUF Comparison July 2025
PARD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PARD stands at 150. In comparison, BPMUF has a market cap of 752.8M. Regarding current trading prices, PARD is priced at $0.00, while BPMUF trades at $61.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PARD currently has a P/E ratio of -0.01, whereas BPMUF's P/E ratio is 8.33. In terms of profitability, PARD's ROE is -1.87%, compared to BPMUF's ROE of -0.01%. Regarding short-term risk, PARD is less volatile compared to BPMUF. This indicates potentially lower risk in terms of short-term price fluctuations for PARD.Check BPMUF's competition here
PARD vs IDRSF Comparison July 2025
PARD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PARD stands at 150. In comparison, IDRSF has a market cap of 732.9M. Regarding current trading prices, PARD is priced at $0.00, while IDRSF trades at $3.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PARD currently has a P/E ratio of -0.01, whereas IDRSF's P/E ratio is -2.11. In terms of profitability, PARD's ROE is -1.87%, compared to IDRSF's ROE of +0.20%. Regarding short-term risk, PARD is less volatile compared to IDRSF. This indicates potentially lower risk in terms of short-term price fluctuations for PARD.Check IDRSF's competition here
PARD vs INRLF Comparison July 2025
PARD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PARD stands at 150. In comparison, INRLF has a market cap of 664.9M. Regarding current trading prices, PARD is priced at $0.00, while INRLF trades at $3.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PARD currently has a P/E ratio of -0.01, whereas INRLF's P/E ratio is -5.84. In terms of profitability, PARD's ROE is -1.87%, compared to INRLF's ROE of -0.43%. Regarding short-term risk, PARD is less volatile compared to INRLF. This indicates potentially lower risk in terms of short-term price fluctuations for PARD.Check INRLF's competition here
PARD vs SOLTF Comparison July 2025
PARD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PARD stands at 150. In comparison, SOLTF has a market cap of 578.3M. Regarding current trading prices, PARD is priced at $0.00, while SOLTF trades at $6.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PARD currently has a P/E ratio of -0.01, whereas SOLTF's P/E ratio is -37.59. In terms of profitability, PARD's ROE is -1.87%, compared to SOLTF's ROE of -0.07%. Regarding short-term risk, PARD is less volatile compared to SOLTF. This indicates potentially lower risk in terms of short-term price fluctuations for PARD.Check SOLTF's competition here
PARD vs CKDXF Comparison July 2025
PARD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PARD stands at 150. In comparison, CKDXF has a market cap of 481.7M. Regarding current trading prices, PARD is priced at $0.00, while CKDXF trades at $0.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PARD currently has a P/E ratio of -0.01, whereas CKDXF's P/E ratio is -1.26. In terms of profitability, PARD's ROE is -1.87%, compared to CKDXF's ROE of +2.04%. Regarding short-term risk, PARD is less volatile compared to CKDXF. This indicates potentially lower risk in terms of short-term price fluctuations for PARD.Check CKDXF's competition here
PARD vs RAONF Comparison July 2025
PARD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PARD stands at 150. In comparison, RAONF has a market cap of 451.7M. Regarding current trading prices, PARD is priced at $0.00, while RAONF trades at $2.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PARD currently has a P/E ratio of -0.01, whereas RAONF's P/E ratio is -43.33. In terms of profitability, PARD's ROE is -1.87%, compared to RAONF's ROE of -0.71%. Regarding short-term risk, PARD is less volatile compared to RAONF. This indicates potentially lower risk in terms of short-term price fluctuations for PARD.Check RAONF's competition here
PARD vs TBGNF Comparison July 2025
PARD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PARD stands at 150. In comparison, TBGNF has a market cap of 433.7M. Regarding current trading prices, PARD is priced at $0.00, while TBGNF trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PARD currently has a P/E ratio of -0.01, whereas TBGNF's P/E ratio is -0.25. In terms of profitability, PARD's ROE is -1.87%, compared to TBGNF's ROE of N/A. Regarding short-term risk, PARD and TBGNF have similar daily volatility (0.00).Check TBGNF's competition here
PARD vs PTCHF Comparison July 2025
PARD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PARD stands at 150. In comparison, PTCHF has a market cap of 425.2M. Regarding current trading prices, PARD is priced at $0.00, while PTCHF trades at $1.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PARD currently has a P/E ratio of -0.01, whereas PTCHF's P/E ratio is 8.43. In terms of profitability, PARD's ROE is -1.87%, compared to PTCHF's ROE of +0.15%. Regarding short-term risk, PARD is less volatile compared to PTCHF. This indicates potentially lower risk in terms of short-term price fluctuations for PARD.Check PTCHF's competition here
PARD vs CLVLY Comparison July 2025
PARD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PARD stands at 150. In comparison, CLVLY has a market cap of 403.2M. Regarding current trading prices, PARD is priced at $0.00, while CLVLY trades at $7.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PARD currently has a P/E ratio of -0.01, whereas CLVLY's P/E ratio is 15.59. In terms of profitability, PARD's ROE is -1.87%, compared to CLVLY's ROE of +0.19%. Regarding short-term risk, PARD is less volatile compared to CLVLY. This indicates potentially lower risk in terms of short-term price fluctuations for PARD.Check CLVLY's competition here
PARD vs CLVLF Comparison July 2025
PARD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PARD stands at 150. In comparison, CLVLF has a market cap of 401M. Regarding current trading prices, PARD is priced at $0.00, while CLVLF trades at $8.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PARD currently has a P/E ratio of -0.01, whereas CLVLF's P/E ratio is 15.69. In terms of profitability, PARD's ROE is -1.87%, compared to CLVLF's ROE of +0.19%. Regarding short-term risk, PARD and CLVLF have similar daily volatility (0.00).Check CLVLF's competition here
PARD vs VBIZF Comparison July 2025
PARD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PARD stands at 150. In comparison, VBIZF has a market cap of 393.2M. Regarding current trading prices, PARD is priced at $0.00, while VBIZF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PARD currently has a P/E ratio of -0.01, whereas VBIZF's P/E ratio is 18.90. In terms of profitability, PARD's ROE is -1.87%, compared to VBIZF's ROE of -0.00%. Regarding short-term risk, PARD is less volatile compared to VBIZF. This indicates potentially lower risk in terms of short-term price fluctuations for PARD.Check VBIZF's competition here
PARD vs HLOSF Comparison July 2025
PARD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PARD stands at 150. In comparison, HLOSF has a market cap of 376M. Regarding current trading prices, PARD is priced at $0.00, while HLOSF trades at $3.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PARD currently has a P/E ratio of -0.01, whereas HLOSF's P/E ratio is -11.08. In terms of profitability, PARD's ROE is -1.87%, compared to HLOSF's ROE of -1.30%. Regarding short-term risk, PARD is less volatile compared to HLOSF. This indicates potentially lower risk in terms of short-term price fluctuations for PARD.Check HLOSF's competition here
PARD vs CLTEF Comparison July 2025
PARD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PARD stands at 150. In comparison, CLTEF has a market cap of 359.4M. Regarding current trading prices, PARD is priced at $0.00, while CLTEF trades at $5.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PARD currently has a P/E ratio of -0.01, whereas CLTEF's P/E ratio is -5.02. In terms of profitability, PARD's ROE is -1.87%, compared to CLTEF's ROE of -0.43%. Regarding short-term risk, PARD is less volatile compared to CLTEF. This indicates potentially lower risk in terms of short-term price fluctuations for PARD.Check CLTEF's competition here
PARD vs NWBO Comparison July 2025
PARD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PARD stands at 150. In comparison, NWBO has a market cap of 345.5M. Regarding current trading prices, PARD is priced at $0.00, while NWBO trades at $0.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PARD currently has a P/E ratio of -0.01, whereas NWBO's P/E ratio is -3.95. In terms of profitability, PARD's ROE is -1.87%, compared to NWBO's ROE of +1.13%. Regarding short-term risk, PARD is less volatile compared to NWBO. This indicates potentially lower risk in terms of short-term price fluctuations for PARD.Check NWBO's competition here
PARD vs CYDY Comparison July 2025
PARD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PARD stands at 150. In comparison, CYDY has a market cap of 344.2M. Regarding current trading prices, PARD is priced at $0.00, while CYDY trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PARD currently has a P/E ratio of -0.01, whereas CYDY's P/E ratio is -13.75. In terms of profitability, PARD's ROE is -1.87%, compared to CYDY's ROE of +0.07%. Regarding short-term risk, PARD is less volatile compared to CYDY. This indicates potentially lower risk in terms of short-term price fluctuations for PARD.Check CYDY's competition here
PARD vs IVEVF Comparison July 2025
PARD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PARD stands at 150. In comparison, IVEVF has a market cap of 317.2M. Regarding current trading prices, PARD is priced at $0.00, while IVEVF trades at $2.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PARD currently has a P/E ratio of -0.01, whereas IVEVF's P/E ratio is -0.66. In terms of profitability, PARD's ROE is -1.87%, compared to IVEVF's ROE of +1.67%. Regarding short-term risk, PARD is less volatile compared to IVEVF. This indicates potentially lower risk in terms of short-term price fluctuations for PARD.Check IVEVF's competition here
PARD vs PBBIF Comparison July 2025
PARD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PARD stands at 150. In comparison, PBBIF has a market cap of 286.9M. Regarding current trading prices, PARD is priced at $0.00, while PBBIF trades at $24.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PARD currently has a P/E ratio of -0.01, whereas PBBIF's P/E ratio is 266.67. In terms of profitability, PARD's ROE is -1.87%, compared to PBBIF's ROE of +0.01%. Regarding short-term risk, PARD is less volatile compared to PBBIF. This indicates potentially lower risk in terms of short-term price fluctuations for PARD.Check PBBIF's competition here
PARD vs PRRUF Comparison July 2025
PARD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PARD stands at 150. In comparison, PRRUF has a market cap of 278.9M. Regarding current trading prices, PARD is priced at $0.00, while PRRUF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PARD currently has a P/E ratio of -0.01, whereas PRRUF's P/E ratio is -9.50. In terms of profitability, PARD's ROE is -1.87%, compared to PRRUF's ROE of -0.28%. Regarding short-term risk, PARD is less volatile compared to PRRUF. This indicates potentially lower risk in terms of short-term price fluctuations for PARD.Check PRRUF's competition here
PARD vs BXPHF Comparison July 2025
PARD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PARD stands at 150. In comparison, BXPHF has a market cap of 277.1M. Regarding current trading prices, PARD is priced at $0.00, while BXPHF trades at $0.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PARD currently has a P/E ratio of -0.01, whereas BXPHF's P/E ratio is -14.13. In terms of profitability, PARD's ROE is -1.87%, compared to BXPHF's ROE of -0.18%. Regarding short-term risk, PARD is less volatile compared to BXPHF. This indicates potentially lower risk in terms of short-term price fluctuations for PARD.Check BXPHF's competition here
PARD vs AVCTF Comparison July 2025
PARD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PARD stands at 150. In comparison, AVCTF has a market cap of 269.3M. Regarding current trading prices, PARD is priced at $0.00, while AVCTF trades at $0.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PARD currently has a P/E ratio of -0.01, whereas AVCTF's P/E ratio is -5.59. In terms of profitability, PARD's ROE is -1.87%, compared to AVCTF's ROE of -1.24%. Regarding short-term risk, PARD and AVCTF have similar daily volatility (0.00).Check AVCTF's competition here
PARD vs ORYZF Comparison July 2025
PARD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PARD stands at 150. In comparison, ORYZF has a market cap of 254.2M. Regarding current trading prices, PARD is priced at $0.00, while ORYZF trades at $3.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PARD currently has a P/E ratio of -0.01, whereas ORYZF's P/E ratio is -46.86. In terms of profitability, PARD's ROE is -1.87%, compared to ORYZF's ROE of -0.05%. Regarding short-term risk, PARD is less volatile compared to ORYZF. This indicates potentially lower risk in terms of short-term price fluctuations for PARD.Check ORYZF's competition here
PARD vs SPHDF Comparison July 2025
PARD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PARD stands at 150. In comparison, SPHDF has a market cap of 237.9M. Regarding current trading prices, PARD is priced at $0.00, while SPHDF trades at $18.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PARD currently has a P/E ratio of -0.01, whereas SPHDF's P/E ratio is -3.17. In terms of profitability, PARD's ROE is -1.87%, compared to SPHDF's ROE of +0.89%. Regarding short-term risk, PARD is less volatile compared to SPHDF. This indicates potentially lower risk in terms of short-term price fluctuations for PARD.Check SPHDF's competition here
PARD vs HNSBF Comparison July 2025
PARD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PARD stands at 150. In comparison, HNSBF has a market cap of 232.3M. Regarding current trading prices, PARD is priced at $0.00, while HNSBF trades at $2.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PARD currently has a P/E ratio of -0.01, whereas HNSBF's P/E ratio is -3.04. In terms of profitability, PARD's ROE is -1.87%, compared to HNSBF's ROE of +1.43%. Regarding short-term risk, PARD is less volatile compared to HNSBF. This indicates potentially lower risk in terms of short-term price fluctuations for PARD.Check HNSBF's competition here
PARD vs NWPHF Comparison July 2025
PARD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PARD stands at 150. In comparison, NWPHF has a market cap of 231.2M. Regarding current trading prices, PARD is priced at $0.00, while NWPHF trades at $12.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PARD currently has a P/E ratio of -0.01, whereas NWPHF's P/E ratio is N/A. In terms of profitability, PARD's ROE is -1.87%, compared to NWPHF's ROE of N/A. Regarding short-term risk, PARD and NWPHF have similar daily volatility (0.00).Check NWPHF's competition here
PARD vs MDCLF Comparison July 2025
PARD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PARD stands at 150. In comparison, MDCLF has a market cap of 230.8M. Regarding current trading prices, PARD is priced at $0.00, while MDCLF trades at $6.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PARD currently has a P/E ratio of -0.01, whereas MDCLF's P/E ratio is -5.21. In terms of profitability, PARD's ROE is -1.87%, compared to MDCLF's ROE of +0.60%. Regarding short-term risk, PARD is less volatile compared to MDCLF. This indicates potentially lower risk in terms of short-term price fluctuations for PARD.Check MDCLF's competition here
PARD vs SLNCF Comparison July 2025
PARD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PARD stands at 150. In comparison, SLNCF has a market cap of 226.7M. Regarding current trading prices, PARD is priced at $0.00, while SLNCF trades at $1.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PARD currently has a P/E ratio of -0.01, whereas SLNCF's P/E ratio is -3.14. In terms of profitability, PARD's ROE is -1.87%, compared to SLNCF's ROE of -0.87%. Regarding short-term risk, PARD is less volatile compared to SLNCF. This indicates potentially lower risk in terms of short-term price fluctuations for PARD.Check SLNCF's competition here
PARD vs CMVLF Comparison July 2025
PARD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PARD stands at 150. In comparison, CMVLF has a market cap of 224.9M. Regarding current trading prices, PARD is priced at $0.00, while CMVLF trades at $3.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PARD currently has a P/E ratio of -0.01, whereas CMVLF's P/E ratio is -4.66. In terms of profitability, PARD's ROE is -1.87%, compared to CMVLF's ROE of -0.46%. Regarding short-term risk, PARD and CMVLF have similar daily volatility (0.00).Check CMVLF's competition here
PARD vs BOVNF Comparison July 2025
PARD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PARD stands at 150. In comparison, BOVNF has a market cap of 216.4M. Regarding current trading prices, PARD is priced at $0.00, while BOVNF trades at $3.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PARD currently has a P/E ratio of -0.01, whereas BOVNF's P/E ratio is -4.38. In terms of profitability, PARD's ROE is -1.87%, compared to BOVNF's ROE of -0.50%. Regarding short-term risk, PARD is less volatile compared to BOVNF. This indicates potentially lower risk in terms of short-term price fluctuations for PARD.Check BOVNF's competition here
PARD vs FPHAF Comparison July 2025
PARD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PARD stands at 150. In comparison, FPHAF has a market cap of 209.5M. Regarding current trading prices, PARD is priced at $0.00, while FPHAF trades at $3.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PARD currently has a P/E ratio of -0.01, whereas FPHAF's P/E ratio is -7.50. In terms of profitability, PARD's ROE is -1.87%, compared to FPHAF's ROE of N/A. Regarding short-term risk, PARD and FPHAF have similar daily volatility (0.00).Check FPHAF's competition here
PARD vs VSBC Comparison July 2025
PARD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PARD stands at 150. In comparison, VSBC has a market cap of 207M. Regarding current trading prices, PARD is priced at $0.00, while VSBC trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PARD currently has a P/E ratio of -0.01, whereas VSBC's P/E ratio is N/A. In terms of profitability, PARD's ROE is -1.87%, compared to VSBC's ROE of +0.00%. Regarding short-term risk, PARD and VSBC have similar daily volatility (0.00).Check VSBC's competition here
PARD vs FGHQF Comparison July 2025
PARD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PARD stands at 150. In comparison, FGHQF has a market cap of 205.6M. Regarding current trading prices, PARD is priced at $0.00, while FGHQF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PARD currently has a P/E ratio of -0.01, whereas FGHQF's P/E ratio is 10.10. In terms of profitability, PARD's ROE is -1.87%, compared to FGHQF's ROE of +0.00%. Regarding short-term risk, PARD is less volatile compared to FGHQF. This indicates potentially lower risk in terms of short-term price fluctuations for PARD.Check FGHQF's competition here
PARD vs CAIHF Comparison July 2025
PARD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PARD stands at 150. In comparison, CAIHF has a market cap of 201M. Regarding current trading prices, PARD is priced at $0.00, while CAIHF trades at $0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PARD currently has a P/E ratio of -0.01, whereas CAIHF's P/E ratio is 7.00. In terms of profitability, PARD's ROE is -1.87%, compared to CAIHF's ROE of +0.05%. Regarding short-term risk, PARD is less volatile compared to CAIHF. This indicates potentially lower risk in terms of short-term price fluctuations for PARD.Check CAIHF's competition here
PARD vs BSEM Comparison July 2025
PARD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PARD stands at 150. In comparison, BSEM has a market cap of 185.4M. Regarding current trading prices, PARD is priced at $0.00, while BSEM trades at $11.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PARD currently has a P/E ratio of -0.01, whereas BSEM's P/E ratio is 8.11. In terms of profitability, PARD's ROE is -1.87%, compared to BSEM's ROE of +1.50%. Regarding short-term risk, PARD is less volatile compared to BSEM. This indicates potentially lower risk in terms of short-term price fluctuations for PARD.Check BSEM's competition here
PARD vs GNFTF Comparison July 2025
PARD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PARD stands at 150. In comparison, GNFTF has a market cap of 185.2M. Regarding current trading prices, PARD is priced at $0.00, while GNFTF trades at $3.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PARD currently has a P/E ratio of -0.01, whereas GNFTF's P/E ratio is 93.00. In terms of profitability, PARD's ROE is -1.87%, compared to GNFTF's ROE of +0.27%. Regarding short-term risk, PARD is less volatile compared to GNFTF. This indicates potentially lower risk in terms of short-term price fluctuations for PARD.Check GNFTF's competition here
PARD vs NGENF Comparison July 2025
PARD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PARD stands at 150. In comparison, NGENF has a market cap of 183.2M. Regarding current trading prices, PARD is priced at $0.00, while NGENF trades at $2.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PARD currently has a P/E ratio of -0.01, whereas NGENF's P/E ratio is -8.97. In terms of profitability, PARD's ROE is -1.87%, compared to NGENF's ROE of -4.00%. Regarding short-term risk, PARD is less volatile compared to NGENF. This indicates potentially lower risk in terms of short-term price fluctuations for PARD.Check NGENF's competition here
PARD vs ADOCY Comparison July 2025
PARD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PARD stands at 150. In comparison, ADOCY has a market cap of 170.4M. Regarding current trading prices, PARD is priced at $0.00, while ADOCY trades at $11.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PARD currently has a P/E ratio of -0.01, whereas ADOCY's P/E ratio is -3.36. In terms of profitability, PARD's ROE is -1.87%, compared to ADOCY's ROE of +1.73%. Regarding short-term risk, PARD and ADOCY have similar daily volatility (0.00).Check ADOCY's competition here
PARD vs BRIBF Comparison July 2025
PARD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PARD stands at 150. In comparison, BRIBF has a market cap of 169.3M. Regarding current trading prices, PARD is priced at $0.00, while BRIBF trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PARD currently has a P/E ratio of -0.01, whereas BRIBF's P/E ratio is -2.31. In terms of profitability, PARD's ROE is -1.87%, compared to BRIBF's ROE of -0.10%. Regarding short-term risk, PARD is less volatile compared to BRIBF. This indicates potentially lower risk in terms of short-term price fluctuations for PARD.Check BRIBF's competition here
PARD vs OPORF Comparison July 2025
PARD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PARD stands at 150. In comparison, OPORF has a market cap of 164.9M. Regarding current trading prices, PARD is priced at $0.00, while OPORF trades at $0.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PARD currently has a P/E ratio of -0.01, whereas OPORF's P/E ratio is 12.00. In terms of profitability, PARD's ROE is -1.87%, compared to OPORF's ROE of +0.42%. Regarding short-term risk, PARD and OPORF have similar daily volatility (0.00).Check OPORF's competition here
PARD vs MLLCF Comparison July 2025
PARD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PARD stands at 150. In comparison, MLLCF has a market cap of 155.6M. Regarding current trading prices, PARD is priced at $0.00, while MLLCF trades at $4.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PARD currently has a P/E ratio of -0.01, whereas MLLCF's P/E ratio is -1.98. In terms of profitability, PARD's ROE is -1.87%, compared to MLLCF's ROE of -0.42%. Regarding short-term risk, PARD is less volatile compared to MLLCF. This indicates potentially lower risk in terms of short-term price fluctuations for PARD.Check MLLCF's competition here
PARD vs SCNLF Comparison July 2025
PARD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PARD stands at 150. In comparison, SCNLF has a market cap of 135.4M. Regarding current trading prices, PARD is priced at $0.00, while SCNLF trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PARD currently has a P/E ratio of -0.01, whereas SCNLF's P/E ratio is -4.35. In terms of profitability, PARD's ROE is -1.87%, compared to SCNLF's ROE of +2.45%. Regarding short-term risk, PARD is less volatile compared to SCNLF. This indicates potentially lower risk in terms of short-term price fluctuations for PARD.Check SCNLF's competition here
PARD vs AAPGV Comparison July 2025
PARD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PARD stands at 150. In comparison, AAPGV has a market cap of 127.3M. Regarding current trading prices, PARD is priced at $0.00, while AAPGV trades at $17.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PARD currently has a P/E ratio of -0.01, whereas AAPGV's P/E ratio is N/A. In terms of profitability, PARD's ROE is -1.87%, compared to AAPGV's ROE of -2.50%. Regarding short-term risk, PARD is less volatile compared to AAPGV. This indicates potentially lower risk in terms of short-term price fluctuations for PARD.Check AAPGV's competition here
PARD vs AMGXF Comparison July 2025
PARD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PARD stands at 150. In comparison, AMGXF has a market cap of 127.1M. Regarding current trading prices, PARD is priced at $0.00, while AMGXF trades at $0.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PARD currently has a P/E ratio of -0.01, whereas AMGXF's P/E ratio is -0.46. In terms of profitability, PARD's ROE is -1.87%, compared to AMGXF's ROE of -0.24%. Regarding short-term risk, PARD is less volatile compared to AMGXF. This indicates potentially lower risk in terms of short-term price fluctuations for PARD.Check AMGXF's competition here
PARD vs IPHYF Comparison July 2025
PARD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PARD stands at 150. In comparison, IPHYF has a market cap of 120.7M. Regarding current trading prices, PARD is priced at $0.00, while IPHYF trades at $1.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PARD currently has a P/E ratio of -0.01, whereas IPHYF's P/E ratio is -1.82. In terms of profitability, PARD's ROE is -1.87%, compared to IPHYF's ROE of -1.81%. Regarding short-term risk, PARD is less volatile compared to IPHYF. This indicates potentially lower risk in terms of short-term price fluctuations for PARD.Check IPHYF's competition here
PARD vs PSTTF Comparison July 2025
PARD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PARD stands at 150. In comparison, PSTTF has a market cap of 117.5M. Regarding current trading prices, PARD is priced at $0.00, while PSTTF trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PARD currently has a P/E ratio of -0.01, whereas PSTTF's P/E ratio is -29.00. In terms of profitability, PARD's ROE is -1.87%, compared to PSTTF's ROE of N/A. Regarding short-term risk, PARD and PSTTF have similar daily volatility (0.00).Check PSTTF's competition here
PARD vs HAVLF Comparison July 2025
PARD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PARD stands at 150. In comparison, HAVLF has a market cap of 112M. Regarding current trading prices, PARD is priced at $0.00, while HAVLF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PARD currently has a P/E ratio of -0.01, whereas HAVLF's P/E ratio is N/A. In terms of profitability, PARD's ROE is -1.87%, compared to HAVLF's ROE of +0.00%. Regarding short-term risk, PARD is less volatile compared to HAVLF. This indicates potentially lower risk in terms of short-term price fluctuations for PARD.Check HAVLF's competition here
PARD vs EPRXF Comparison July 2025
PARD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PARD stands at 150. In comparison, EPRXF has a market cap of 108.3M. Regarding current trading prices, PARD is priced at $0.00, while EPRXF trades at $3.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PARD currently has a P/E ratio of -0.01, whereas EPRXF's P/E ratio is -2.69. In terms of profitability, PARD's ROE is -1.87%, compared to EPRXF's ROE of -0.85%. Regarding short-term risk, PARD is less volatile compared to EPRXF. This indicates potentially lower risk in terms of short-term price fluctuations for PARD.Check EPRXF's competition here
PARD vs ADOIF Comparison July 2025
PARD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PARD stands at 150. In comparison, ADOIF has a market cap of 103.7M. Regarding current trading prices, PARD is priced at $0.00, while ADOIF trades at $8.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PARD currently has a P/E ratio of -0.01, whereas ADOIF's P/E ratio is -2.59. In terms of profitability, PARD's ROE is -1.87%, compared to ADOIF's ROE of +6.08%. Regarding short-term risk, PARD and ADOIF have similar daily volatility (0.00).Check ADOIF's competition here
PARD vs JWCTF Comparison July 2025
PARD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PARD stands at 150. In comparison, JWCTF has a market cap of 101.3M. Regarding current trading prices, PARD is priced at $0.00, while JWCTF trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PARD currently has a P/E ratio of -0.01, whereas JWCTF's P/E ratio is -1.25. In terms of profitability, PARD's ROE is -1.87%, compared to JWCTF's ROE of -0.47%. Regarding short-term risk, PARD and JWCTF have similar daily volatility (0.00).Check JWCTF's competition here
PARD vs PRNAF Comparison July 2025
PARD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PARD stands at 150. In comparison, PRNAF has a market cap of 96.7M. Regarding current trading prices, PARD is priced at $0.00, while PRNAF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PARD currently has a P/E ratio of -0.01, whereas PRNAF's P/E ratio is -0.30. In terms of profitability, PARD's ROE is -1.87%, compared to PRNAF's ROE of -1.77%. Regarding short-term risk, PARD is less volatile compared to PRNAF. This indicates potentially lower risk in terms of short-term price fluctuations for PARD.Check PRNAF's competition here
PARD vs TRGNF Comparison July 2025
PARD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PARD stands at 150. In comparison, TRGNF has a market cap of 92.7M. Regarding current trading prices, PARD is priced at $0.00, while TRGNF trades at $0.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PARD currently has a P/E ratio of -0.01, whereas TRGNF's P/E ratio is -2.06. In terms of profitability, PARD's ROE is -1.87%, compared to TRGNF's ROE of -3.14%. Regarding short-term risk, PARD is less volatile compared to TRGNF. This indicates potentially lower risk in terms of short-term price fluctuations for PARD.Check TRGNF's competition here
PARD vs PBIGF Comparison July 2025
PARD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PARD stands at 150. In comparison, PBIGF has a market cap of 90.9M. Regarding current trading prices, PARD is priced at $0.00, while PBIGF trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PARD currently has a P/E ratio of -0.01, whereas PBIGF's P/E ratio is -5.71. In terms of profitability, PARD's ROE is -1.87%, compared to PBIGF's ROE of -2.16%. Regarding short-term risk, PARD is less volatile compared to PBIGF. This indicates potentially lower risk in terms of short-term price fluctuations for PARD.Check PBIGF's competition here